Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
Authors
Keywords
-
Journal
JAMA Dermatology
Volume 157, Issue 9, Pages 1047
Publisher
American Medical Association (AMA)
Online
2021-08-05
DOI
10.1001/jamadermatol.2021.3023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Kristian Reich et al. LANCET
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
- (2021) Emma Guttman-Yassky et al. LANCET
- What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Atopic dermatitis
- (2020) Sinéad M Langan et al. LANCET
- Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
- (2020) Jonathan I. Silverberg et al. JAMA Dermatology
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- (2019) Michael D. Howell et al. Frontiers in Immunology
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- A Comprehensive Conceptual Model of the Experience of Chronic Itch in Adults
- (2018) Jonathan I. Silverberg et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- JAK Inhibitors for Atopic Dermatitis: An Update
- (2018) Helen He et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches
- (2014) Donald Y.M. Leung et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Determinants of treatment goals and satisfaction of patients with atopic eczema
- (2008) Jochen Schmitt et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started